WPRIM Management System> DCMS> Chinese Journal of Cardiology> 2012> 40> 5

Volume: 40 Issue: 5

1. Advances of experimental vaccination for prevention and treatment of atherosclerosis. Page:442—445
2. Association between C-reactive protein gene polymorphisms/haplotypes and serum levels and related diseases. Page:439—441
3. Electrocardiograph resembles acute ST segment elevation myocardial infarction in pheochromocytoma crisis: a case report. Page:437—438
4. One case of acute coronary syndrome caused by prosthetic aortic valve dysfunction. Page:436—437
5. Plasma lipid level and incidence of dyslipidemia in workers of Chongqing enterprises and institutions. Page:432—435
6. Epidemiological survey on pre-hypertension and hypertension prevalence among adolescents aged 11 to 17 years in Shanghai. Page:427—431
7. Effects of docosahexaenoic acid on ion channels of rat coronary artery smooth muscle cells. Page:421—426
8. Acute pulmonary thromboembolism without D dimmer elevation in one patient. Page:420—420
9. Expression of extracellular matrix metalloproteinase inducer in the unstable plaque of patients with acute coronary syndrome. Page:416—420
10. Role of triggering receptor expressed on myeloid cells-1 on coxsackievirus B3-induced inflammation and cardiomyocyte injury. Page:411—415
11. MicroRNAs expression in normal and dissected aortic tissue. Page:406—410
12. Metalloproteinase Tolloid-like 1 gene mutation in Chinese patients with sporadic congenital heart diseases. Page:402—405
13. Impact of metabolic syndrome on cardio-cerebral vascular events in pre-hypertensive population. Page:397—401
14. Effects of myocardial platelet rich plasma injection on rats with acute myocardial infarction:(99)Tc(m)-MIBI gated SPECT imaging evaluation results. Page:392—396
15. Association study on the microRNA-1 target gene polymorphism and the risk of premature coronary artery disease. Page:386—391
16. Clinical and coronary features of systemic lupus erythematosus patients with coronary artery disease. Page:382—385
17. Clinical manifestations of patients with systemic lupus erythematosus and coronary artery disease. Page:378—381
18. Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome. Page:373—377
19. Re-evaluation on the adverse effects of statins. Page:371—372
20. Systemic lupus erythematosus and premature atherosclerosis. Page:368—370